Literature DB >> 12937414

T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura.

Bob Olsson1, Per-Ola Andersson, Margareta Jernås, Stefan Jacobsson, Björn Carlsson, Lena M S Carlsson, Hans Wadenvik.   

Abstract

Chronic idiopathic thrombocytopenic purpura (ITP) is a bleeding disorder that is characterized by increased platelet destruction and is believed to be autoantibody mediated. In this study, CD3+ T cells from ITP patients had increased expression of genes involved in cell-mediated cytotoxicity. In addition, cytotoxic cell-mediated lysis of autologous platelets was shown in active ITP. Our data suggest that T-cell-mediated cytotoxicity is an alternative mechanism for platelet destruction in ITP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937414     DOI: 10.1038/nm921

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  141 in total

Review 1.  Piecing together the humoral and cellular mechanisms of immune thrombocytopenia.

Authors:  Lisa J Toltl; Ishac Nazi; Reza Jafari; Donald M Arnold
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

2.  Immune thrombocytopenia in children and adults: what's the same, what's different?

Authors:  Harald Schulze; Gerhard Gaedicke
Journal:  Haematologica       Date:  2011-12       Impact factor: 9.941

Review 3.  Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.

Authors:  Lisa J Toltl; Donald M Arnold
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

4.  CD8+ T cells mediate antibody-independent platelet clearance in mice.

Authors:  Connie M Arthur; Seema R Patel; H Cliff Sullivan; Annie M Winkler; Chris A Tormey; Jeanne E Hendrickson; Sean R Stowell
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

5.  Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.

Authors:  Jiang Cao; Chong Chen; Li Li; Zeng Ling-yu; Li Zhen-yu; Yan Zhi-ling; Chen Wei; Cheng Hai; Wei Sang; Xu Kai-lin
Journal:  J Clin Immunol       Date:  2012-06       Impact factor: 8.317

Review 6.  Immune thrombocytopenia and pregnancy.

Authors:  Srividhya Sankaran; Susan E Robinson
Journal:  Obstet Med       Date:  2011-10-25

7.  Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients.

Authors:  Anil Kumar Tripathi; Ayush Shukla; Sanjay Mishra; Yogendra Singh Yadav; Deependra Kumar Yadav
Journal:  Int J Hematol       Date:  2014-02-14       Impact factor: 2.490

Review 8.  Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.

Authors:  Shi-Yang Guan; Rui-Xue Leng; Muhammad Imran Khan; Humera Qureshi; Xiang-Pei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

Review 9.  Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

Authors:  Dong Zheng; Chen-Song Huang; Shao-Bin Huang; Chao-Xu Zheng
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

10.  Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.

Authors:  Reut Gurion; Anita Siu; Aaron R Weiss; Margaret Masterson
Journal:  J Pediatr Pharmacol Ther       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.